Abstract
Objective: This study aimed to characterize the phenotype of a novel myalgic myopathy encountered in a Finnish family.
Methods: Four symptomatic and three asymptomatic individuals from two generations underwent clinical, neurophysiological, imaging, and muscle biopsy examinations. Targeted sequencing of all known myopathy genes was performed.
Results: A very rare CACNA1S gene variant c.2893G>C (p.E965Q) was identified in the family. The symptomatic patients presented with exercise-induced myalgia, cramping, muscle stiffness, fatigue, and, eventually, developed muscle weakness. Examinations revealed mild ptosis and unusual muscle hypertrophy in the upper limbs. In the most advanced disease stage muscle weakness and muscle atrophy of the limbs were evident. In some patients muscle biopsy showed mild myopathic findings and creatine kinase (CK) levels were slightly elevated.
Discussion: Myalgia is a very common symptom affecting the quality of life. Widespread myalgia may be confused with other myalgic syndromes such as fibromyalgia. In this study we show that variants in CACNA1S gene may be one cause of severe exercise-induced myalgia.
- Received March 1, 2023.
- Accepted in final form May 30, 2023.
- © 2023 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
